P3‐422: A placebo‐controlled pilot discontinuation trial following haloperidol treatment of behavioral and psychotic symptoms in Alzheimer's disease

Subjects

Subjects :

medicine.medical_specialty
Epidemiology
business.industry
Health Policy
Disease
Placebo
Discontinuation
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Internal medicine
medicine
Physical therapy
Haloperidol
Neurology (clinical)
Geriatrics and Gerontology
business
medicine.drug

Details

ISSN :

15525279 and 15525260

Volume :

6

Database :

OpenAIRE

Journal :

Alzheimer's & Dementia

Accession number :

edsair.doi...........3ab1c311c09826562df03c8463d74a4e

Full Text :

https://doi.org/10.1016/j.jalz.2010.05.1965